Boston Scientific Corp., 10% Owner at Pulmonx Corp (LUNG), sold 650,000 shares at $43.60 ($28.3M) on 2021-04-06, disclosed to the SEC on 2021-04-08.
Open-market sale of $28.3M LUNG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| IMRX | SELL | 2008-09-19 | $400K | — | Filing → |
| CYBX | SELL | 2007-10-05 | $48.6M | — | Filing → |
| NSTR | SELL | 2007-07-26 | $32.5M | — | Filing → |